Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
13.30
+0.30 (2.31%)
At close: May 13, 2025, 4:00 PM
13.27
-0.03 (-0.23%)
Pre-market: May 14, 2025, 7:00 AM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Laboratory Solutions | 4.52B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Solutions Growth | -3.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bioscience Production | 2.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bioscience Production Growth | -0.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Proprietary Materials & Consumables | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Proprietary Materials & Consumables Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Third Party Materials & Consumables | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Third Party Materials & Consumables Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services & Specialty Procurement | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services & Specialty Procurement Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Equipment & Instrumentation | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Equipment & Instrumentation Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2019 |
| Americas Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMEA Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMEA Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2019 |
| Americas Adjusted EBITDA |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Adjusted EBITDA Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Adjusted EBITDA |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Adjusted EBITDA Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMEA Adjusted EBITDA |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMEA Adjusted EBITDA Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted EBITDA |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted EBITDA Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2019 |
| Americas |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMEA |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMEA Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Laboratory Solutions Adjusted Operating Income | 588.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Solutions Adjusted Operating Income Growth | -6.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bioscience Production Adjusted Operating Income | 554.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bioscience Production Adjusted Operating Income Growth | -2.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted Operating Income | -69.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted Operating Income Growth | 17.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|